| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/29/2011 | CN102106811A Ivermectin mixed micelle injection and preparation method thereof |
| 06/29/2011 | CN102106810A Medicinal solid composition containing cephalosporin antibiotics and preparation method thereof |
| 06/29/2011 | CN102106809A Solid preparation of clopidogrel and preparation method thereof |
| 06/29/2011 | CN102106808A Solid preparation and preparation method thereof |
| 06/29/2011 | CN102106807A Method for preparing solid preparation and solid preparation |
| 06/29/2011 | CN102106806A Method for preparing solid preparation and solid preparation |
| 06/29/2011 | CN102106804A Novel percutaneous preparation formed by nanowires containing porous structures |
| 06/29/2011 | CN101912376B Matrine vaginal effervescent tablets with bilayer structure and preparation method |
| 06/29/2011 | CN101744815B Composite medicament of omeprazole sodium |
| 06/29/2011 | CN101716346B Supramolecular hydrogel gene vector material, and preparation method and application thereof |
| 06/29/2011 | CN101658497B Dual drug-loading composite microsphere and preparation method thereof |
| 06/29/2011 | CN101642550B Plaster for treating chronic gastroenteritis and preparation method thereof |
| 06/29/2011 | CN101642518B Plaster for treating dysmenorrhea |
| 06/29/2011 | CN101632636B Taxol lipid preparation and method for preparing same |
| 06/29/2011 | CN101627969B Novel curcumin self-emulsifying drug delivery system and preparation method thereof |
| 06/29/2011 | CN101584750B Compound fig preparation |
| 06/29/2011 | CN101579480B Medicinal dripping pill for treating hypertension |
| 06/29/2011 | CN101579411B Medicinal dripping pill for treating prostatauxe |
| 06/29/2011 | CN101530394B Preparation method of polypeptide-chitosan composite nanoparticles loaded with coenzyme Q10 |
| 06/29/2011 | CN101507738B Preparation method of Shu Xuening injection |
| 06/29/2011 | CN101502491B Dirithromycin enteric-coated formulation |
| 06/29/2011 | CN101485887B 5-fluorouracil-sn2-phosphatidyl choline copolymer as well as preparation method and application thereof |
| 06/29/2011 | CN101461799B Stable pravastatin medicament composition and preparation method thereof |
| 06/29/2011 | CN101396563B Chitose derivates using octreotide as target ligand and use thereof in medicament |
| 06/29/2011 | CN101368187B Recombinant human FUS1 and human IL-12 dual-gene expression carrier, liposome complexes, preparation method and application thereof |
| 06/29/2011 | CN101306181B Elemene fat emulsion injection and preparation method thereof |
| 06/29/2011 | CN101301328B Medicament for treating pyogenic skin infection and carbuncle-abscess |
| 06/29/2011 | CN101048180B Solid formulation with improved solubility and stability, and method for producing said formulation |
| 06/28/2011 | US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968512 Conjugates that contain the homeodomain of antennapedia |
| 06/28/2011 | US7968125 Energy generating composition |
| 06/28/2011 | US7968123 Complexing agents for compositions containing inclusion complexes |
| 06/28/2011 | US7968120 Modified release dosage forms |
| 06/28/2011 | US7968112 Lipids containing omega-3 and omega-6 fatty acids |
| 06/28/2011 | CA2544432C Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 06/28/2011 | CA2531687C Thermosensitive polymers for therapeutic use and methods of preparation |
| 06/28/2011 | CA2465832C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/28/2011 | CA2458313C Zeacarotene colorant for food and pharmaceuticals |
| 06/28/2011 | CA2445841C Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds |
| 06/28/2011 | CA2377909C Pharmaceutical composition containing fenofibrate and preparation method |
| 06/28/2011 | CA2338909C Methods, instruments and materials for chondrocyte cell transplantation |
| 06/23/2011 | WO2011075623A1 One - phase gel compos ition compri s ing phos pholi pids |
| 06/23/2011 | WO2011075516A2 Active scaffolds for on-demand drug and cell delivery |
| 06/23/2011 | WO2011075500A2 Stabilization of therapeutic agents to facilitate administration |
| 06/23/2011 | WO2011074782A2 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine |
| 06/23/2011 | WO2011074670A1 Liquid food composition |
| 06/23/2011 | WO2011074660A1 Elution-stabilized preparation |
| 06/23/2011 | WO2011074637A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074636A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074635A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074578A1 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability |
| 06/23/2011 | WO2011074567A1 Transdermal preparation containing basic anti-inflammatory agent |
| 06/23/2011 | WO2011074566A1 Felbinac-containing transdermal absorption preparation |
| 06/23/2011 | WO2011074565A1 Piroxicam-containing endermic preparation |
| 06/23/2011 | WO2011073998A1 Composition of dexibuprofen transdermal hydrogel |
| 06/23/2011 | WO2011073991A1 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
| 06/23/2011 | WO2011073906A1 Polyethylene glycol containing composition for shaving |
| 06/23/2011 | WO2011073473A1 Vinyl sulphone functionalised lipid systems. synthesis and uses |
| 06/23/2011 | WO2011073395A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | WO2011073392A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | WO2011073328A1 Glp-1 receptor agonist compounds with a modified n-terminus |
| 06/23/2011 | WO2011073234A2 Growth hormone composition |
| 06/23/2011 | WO2011073134A1 Pharmaceutical composition for treatment of dry eye syndrome |
| 06/23/2011 | WO2011073054A1 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs |
| 06/23/2011 | WO2011072627A2 Dendritic high-molecular-weight polymer drug carriers and their conjugates with drugs especially for treatment of solid tumours |
| 06/23/2011 | WO2011072557A1 ALGINATE-ε-POLYLYSINE MICROCAPSULE, ITS PREPARATION METHOD AND APPLICATION |
| 06/23/2011 | WO2011072510A1 Passive solid tumor targeting anticancer prodrug and preparation method thereof |
| 06/23/2011 | WO2011072399A1 Injectable polymer composition for use as a cell delivery vehicle |
| 06/23/2011 | WO2011072398A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | WO2011072393A1 Decellularized adipose tissue |
| 06/23/2011 | WO2011053139A3 Aqueous composition for topical application, method of preparation, uses and device |
| 06/23/2011 | WO2011028334A3 Synthesis and isolation of dendrimer systems |
| 06/23/2011 | WO2011027365A3 Ophthalmic compositions containing dorzolamide, timolol and brimonidine |
| 06/23/2011 | WO2011027174A3 Composition |
| 06/23/2011 | WO2011025035A9 Coating composition |
| 06/23/2011 | WO2011014588A3 Dermal formulations of dp2 receptor antagonists |
| 06/23/2011 | WO2011009106A3 Methods and compositions for in vitro and in vivo chondrogenesis |
| 06/23/2011 | WO2011000489A3 Novel esters, and use thereof |
| 06/23/2011 | WO2010089775A3 Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent |
| 06/23/2011 | WO2010061193A3 Compositions with reduced dimer formation |
| 06/23/2011 | US20110153027 Drug Delivery System |
| 06/23/2011 | US20110152384 Mild leave-on skin care compositions |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152335 Allantoin-containing skin cream |
| 06/23/2011 | US20110152307 Ophthalmic composition comprising ascomycin |
| 06/23/2011 | US20110152216 Anaesthetic composition |
| 06/23/2011 | US20110152198 Pharmaceutical compositions containing botulinum toxin |
| 06/23/2011 | US20110152195 Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
| 06/23/2011 | US20110152190 Erodible polymers for injection |
| 06/23/2011 | US20110152167 Biodegradable block polymers for drug delivery, and methods related thereto |
| 06/23/2011 | US20110151014 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients |
| 06/23/2011 | US20110151011 Decellularized Adipose Tissue |
| 06/23/2011 | US20110150985 Methods for preparing pharmaceuticals by emulsion aggregation processes |
| 06/23/2011 | US20110150984 Methods of increasing the bioavailability and/or cellular update of drugs |
| 06/23/2011 | US20110150973 Electrospun dextran fibers and devices formed therefrom |
| 06/23/2011 | US20110150972 Medical devices having improved performance |
| 06/23/2011 | US20110150966 Degradable polymers incorporating gamma-butyrolactone |
| 06/23/2011 | US20110150953 Method for producing vesicle, vesicle obtained by the production method, and w/o/w emulsion for producing vesicle |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |